Background
==========

Abnormal distribution, modification and aggregation of transactivation response DNA-binding protein 43 (TDP-43) are the hallmarks of multiple neurodegenerative diseases, especially frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS).

Results
=======

To explore the pathogenic properties of mutant forms of TDP-43, we generated and characterized two mouse lines expressing human TDP-43 carrying the M337V mutation (hTDP-43~M337V~). We found hTDP-43~M337V~ was expressed primarily in the nuclei of neurons in the brain and spinal cord, intranuclear and cytoplasmic phosphorylated TDP-43 aggregates were frequently detected, and the levels of TDP-43 LMW products of \~25 kDa and \~35 kDa species were also increased. Overexpression of hTDP-43~M337V~ dramatically down regulated the levels of mouse TDP-43 (mTDP-43) protein and RNA, indicating TDP-43 levels are tightly controlled in mammalian systems. TDP-43~M337V~ mice displayed reactive gliosis, widespread ubiquitination, chromatolysis, gait abnormalities, and early lethality. Abnormal cytoplasmic mitochondrial aggregates and abnormal phosphorylated tau were also detected in the mice.

Conclusion
==========

While overexpression of hTDP-43 in wild-type TDP-43 and TDP-43~M337V~ mouse models produces similar phenotypes, our results suggest that overexpression of the hTDP-43~M337V~ can cause neuronal dysfunction due to its effect on a number of cell organelles and proteins, such as mitochondria and TDP-43, that are critical for neuronal activity.
